Keith Berelowitz, Richmond Pharmacology’s Director of Operations, wrote recently for Pharmaceutical Market Europe where he outlined methods that facilitate the successful recruitment and retention of patients - an essential element to delivering clinical studies on time.

The article focuses on the growing emphasis on improved patient engagement in trial development.  A key element in the success of clinical trials lies in the availability and subsequent experience of people volunteering to participate. It is therefore crucial that Richmond Pharmacology and trial sponsors understand patients’ lives and the factors that drive a patient’s decision to take part in a study. Examples are shared in the article about effective ways of doing this.

Richmond Pharmacology understands the importance of having a good relationship with patient volunteers. This can be achieved by removing potential barriers to trial participation, as well as ensuring that the volunteer is treated as an individual, rather than given a one-size-fits-all experience. Keith also highlights other criteria that sponsors should look for in a Contract Research Organisation (CRO) regarding patient retention – for example a guarantee that a trial will take place in a single centre research facility and that interaction with patients is never outsourced to a third party.

To read the full article, click here

Latest news


May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event